I did read it. They call it a "product" and later a "medication".
If I'm not mistaken they only recently finished a phase 2a trial of 6 weeks, but I have not seen a phase 3 trial and regulator approval necessary for it to be called a medicine. If I'm mistaken about the process, mea culpa. This is why I ask.
If it's not medicine I wonder if the price they want to sell for is not high for a supplement, but I admit I don't know that specific market at all.
CannEpil™ — The first product from MGC Pharma, page-7
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.035(8.86%) |
Mkt cap ! $16.30M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 36.0¢ | $8.939K | 24.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3231 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 50 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
36.5¢ |
Change
-0.035 ( 1.35 %) |
||||
| Open | High | Low | Volume | ||
| 36.5¢ | 36.5¢ | 36.5¢ | 550 | ||
| Last updated 12.29pm 29/05/2024 ? | |||||
| RGT (ASX) Chart |